Our clinical and cell manipulation expertise is paramount in haematology, cancer immunotherapy other anticancer approaches, as well as regenerative medicine stem cell therapy.
We offer an excellent opportunity to conduct and supply multi-center clinical trials in North America
CETC’s cell manufacturing capabilities include (i) translational expertise and “scale-up” solutions as well as (ii) GMP production and all necessary (iii) standardization for clinical development.
includes the development, scale-up and CGMP clinical production of cells for Immuno-oncology therapies. (In capabilities section)
